How Do Fluence And Passing Techniques On A 1450 Nm Laser Affect Acne Treatment And Pain?

In clinical practice, a high-fluence single pass generally maximizes acne clearance, while a lower-fluence double pass can substantially improve comfort with only a moderate reduction in efficacy. On a 1450 nm diode laser, protocols such as 12–14 J/cm² in one pass have produced inflammatory lesion reductions of approximately 78%, but average pain may reach 5.6/10. A double pass at approximately 8 J/cm² per pass can reduce reported pain to about 1.3/10 while still achieving roughly 67% lesion reduction.

The best protocol is not defined by fluence alone. It balances sufficient dermal heating of sebaceous glands against tolerability, cooling, skin response, and the patient’s ability to complete a treatment series.

How Fluence Influences Acne Treatment

Why 1450 nm energy targets acne

The 1450 nm wavelength penetrates into the mid-dermis, where sebaceous glands are located. Because the energy is primarily absorbed by tissue water, it produces controlled photothermal heating that can reduce sebaceous activity and inflammatory acne.

The epidermis is relatively protected by the wavelength’s penetration characteristics and by integrated dynamic epidermal cooling. The therapeutic objective is therefore selective dermal heating without excessive surface injury.

What higher fluence contributes

A single pass at 12–14 J/cm² delivers a relatively intense thermal exposure to the target tissue. In the cited clinical results, this approach produced approximately 78% reduction in inflammatory acne lesions.

The trade-off is a stronger heat sensation and greater procedural discomfort. High-fluence treatment may therefore be clinically effective but less acceptable for patients who are pain-sensitive or anxious about laser procedures.

Why lower fluence can still work

A lower-energy double pass, such as 8 J/cm² per pass, distributes treatment into two exposures rather than one high-intensity exposure. This can still generate meaningful cumulative thermal treatment while reducing the intensity of each individual pass.

The reported outcome was approximately 67% lesion reduction. That is lower than the cited high-fluence result, but it remains clinically substantial and may be preferable when comfort and treatment adherence are priorities.

Total fluence is not the whole explanation

Two passes at 8 J/cm² represent a nominal total of 16 J/cm², but the biological effect cannot be predicted by simply adding the numbers. Tissue temperature, time between passes, cooling, spot overlap, pulse delivery, and heat dissipation all influence the final treatment effect.

For this reason, a double-pass protocol should be treated as a distinct delivery strategy rather than assumed to be identical to a 16 J/cm² single pass.

How Passing Technique Affects Patient Pain

Why single-pass treatment feels more intense

A high-fluence single pass deposits substantial energy in a short treatment event. Patients commonly experience this as a concentrated heat or snapping sensation, particularly over inflamed lesions and areas with dense sebaceous activity.

The cited average pain rating of 5.6/10 indicates that discomfort can be clinically significant, even when the treatment remains tolerable for some patients.

Why double-pass treatment may be more comfortable

The lower-energy double-pass technique reduces the energy delivered during each individual pass. This can make the sensation less intense and easier for the patient to tolerate.

In the cited comparison, average pain decreased from 5.6/10 to 1.3/10. That difference is large enough to affect willingness to complete multiple sessions and to improve the overall treatment experience.

Comfort affects real-world efficacy

A protocol with slightly higher lesion clearance is not necessarily the best clinical choice if patients refuse treatment, require repeated interruptions, or do not return for subsequent sessions.

A lower-fluence double-pass approach may produce a lower per-treatment clearance figure while improving compliance, completion of the treatment series, and patient satisfaction. Those practical factors can determine the outcome achieved in routine practice.

Using Cooling and Other Comfort Measures

Dynamic epidermal cooling

Integrated dynamic epidermal cooling helps protect the skin surface during delivery. It can reduce excessive epidermal heating and make higher-energy treatment more tolerable.

Cooling should support, not replace, appropriate fluence selection. It does not eliminate the need to monitor pain, erythema, swelling, and other treatment responses.

Topical anesthesia

Topical anesthesia may be considered when discomfort is expected to be substantial, particularly with higher-fluence treatment. Its use should follow the device protocol, product instructions, and standard clinical safety practices.

Anesthetic preparation should not encourage clinicians to use unnecessarily aggressive settings. Pain control is intended to improve tolerability, not to mask an excessive tissue response.

Treatment response monitoring

Pain scores should be assessed during and after treatment rather than inferred from the selected fluence alone. Marked pain, excessive erythema, or disproportionate swelling should prompt reassessment of settings, cooling, technique, and patient-specific factors.

Transient erythema, localized edema, itching, and occasional temporary hyperpigmentation have been reported. These reactions are usually limited, but skin phototype and individual susceptibility remain important considerations.

Understanding the Trade-offs

Maximum clearance versus comfort

The high-fluence single-pass approach offers the stronger cited lesion reduction: approximately 78% versus 67% with the lower-energy double pass. Its disadvantage is substantially greater discomfort.

The double-pass approach therefore does not provide identical efficacy in the cited comparison. Its value lies in preserving robust acne improvement while markedly reducing pain.

Avoiding fluence-only decision-making

Fluence should not be selected in isolation. The clinical result also depends on the number of sessions, spacing between treatments, treatment area, spot placement, cooling, and the patient’s acne severity and skin characteristics.

Reported multi-session outcomes across 1450 nm protocols vary widely, generally reflecting differences in these treatment variables. Results from one protocol should not automatically be applied to another device or patient population.

Avoiding the assumption that more pain means better treatment

Pain is not a reliable surrogate for therapeutic success. Excessive discomfort can reduce cooperation, increase treatment anxiety, and compromise future attendance without proving that the sebaceous glands received a superior therapeutic dose.

The goal is controlled therapeutic heating, not maximal pain or maximal fluence.

Considering darker skin phototypes

The 1450 nm platform has been used in patients with darker Fitzpatrick skin phototypes, including IV–VI, with generally favorable safety reports. However, post-inflammatory hyperpigmentation remains a possible adverse effect, so conservative parameter selection and careful monitoring are still necessary.

Patient selection, cooling, and response-based adjustments are especially important when the consequences of excessive inflammation may be more visible or prolonged.

How to Apply This to Clinical Practice

The appropriate choice should be based on the desired balance between clearance, tolerability, and the likelihood of completing the treatment course.

If your primary focus is maximum lesion reduction: Consider a high-fluence single-pass protocol in the approximate 12–14 J/cm² range when clinically appropriate, with active cooling and close monitoring of discomfort and skin response.
If your primary focus is pain reduction and adherence: Consider a lower-energy double-pass approach such as 8 J/cm² per pass, which may reduce pain substantially while retaining meaningful acne clearance.
If your primary focus is individualized treatment: Adjust fluence, pass strategy, cooling, and supportive comfort measures according to pain response, skin type, acne severity, and treatment tolerance.
If your primary focus is long-term outcomes: Favor the protocol the patient can reliably complete, because a well-tolerated multi-session course may be more valuable than a more aggressive protocol that limits adherence.

The most effective 1450 nm acne protocol is the one that delivers adequate sebaceous-gland heating while keeping treatment comfortable enough for the patient to continue.

Summary Table:

Protocol	Fluence (J/cm²)	Lesion Reduction	Pain Score (0–10)	Key Advantage
Single Pass	12–14	~78%	5.6	Maximum efficacy
Double Pass	~8 per pass	~67%	1.3	Greater comfort

Looking to integrate advanced laser technology into your practice? BELIS specializes in professional-grade medical aesthetic equipment for clinics and premium salons. Our portfolio includes cutting-edge diode laser systems designed for effective acne treatment with customizable protocols to balance efficacy and patient comfort. With OEM/ODM support, comprehensive certifications, and reliable supply, we help you deliver superior care and grow your business. Contact us today to explore how our solutions can elevate your offerings and drive patient satisfaction. Get in touch with our team now.